Search results for alzheimer's

“Researchers believe the disease is caused by toxic levels of beta-amyloid protein aggregates in the brain that impair neuronal function and trigger cognitive decline. While this process is partly under the influence of genes, studies also indicate links between Alzheimer’s and external factors such as head injury.”

“Additionally, nicotinamide mononucleotide treatment significantly decreased beta-amyloid production and inflammatory responses, both of which may be mediators of Alzheimer's disease progression.”

“Alzheimer’s disease is a neurodegenerative disorder characterized by progressive memory loss, cognitive decline, and behavioral changes. Roughly 50 million people have Alzheimer's disease worldwide.”

“A control group would allow us to compare and clearly identify if creatine preserves, slows, or improves cognitive function beyond the expected decline seen in Alzheimer's. Without this comparison, we can't confidently separate the effects of creatine from typical disease progression.”

“Although this study demonstrated that resveratrol treatment may improve parameters associated with Alzheimer's disease, larger and longer studies are needed to determine whether resveratrol can promote cognitive and functional improvement.”

“Those who took benzodiazepines for six months had an almost double risk of an Alzheimer’s diagnosis. The relationship worked in a dose-dependent manner, meaning that the longer a person took the medications or the higher the dose, the higher the risk of developing Alzheimer’s.”

“Zinc and Alzheimer’s disease Currently, there is no consensus as to whether zinc concentrations in the brain are altered during Alzheimer’s disease progression. Some studies have demonstrated that zinc concentrations increase with Alzheimer's disease, while others demonstrate the converse.”

“A recent study shows that long-term flavonoid intake reduces the risk of Alzheimer's disease and related forms of dementia. Alzheimer's disease is a neurodegenerative disorder characterized by problems with memory, learning, and decision-making.”

“The risk reduction associated with light to moderate drinking may be as high as 26%–28% for dementia and Alzheimer's disease. A more modest 10% reduction in the risk of dementia may occur at four drinks per week.”

“Findings from a recent study suggest that amyloid-beta produced in tissues outside the brain provides the link between type 2 diabetes and Alzheimer’s disease. Amyloid-beta, a toxic peptide produced in the brain, clumps together and forms plaques with age.”